Hawaii GLP-1 Lawsuit Overview
If you live in Hawaii and were diagnosed with NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) after taking a GLP-1 drug such as Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity, or Rybelsus, you may be eligible to file a claim in the federal GLP-1 NAION MDL (MDL 3163).
All GLP-1 NAION claims — regardless of where the plaintiff lives — are consolidated in MDL 3163 in the Eastern District of Pennsylvania under Judge Karen Marston. You do not need to travel to Pennsylvania to file. Your local attorney can handle your case as part of the MDL.
2 Years
Discovery Rule May Apply
Hawaii Statute of Limitations Details
Hawaii generally has a 2-year period for personal injury claims, and accrual/discovery issues should be evaluated for latent pharmaceutical injuries.
Who Qualifies in Hawaii?
To file a GLP-1 NAION claim as a Hawaii resident, you generally need:
- A documented prescription for Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, or Trulicity
- An ophthalmologist's diagnosis of NAION or sudden optic nerve-related vision loss
- NAION developed during or after your GLP-1 drug use (not before)
- Filing within Hawaii's 2-year statute of limitations window
How the MDL Works for Hawaii Residents
Even though MDL 3163 is located in Pennsylvania, Hawaii residents can participate without traveling. Here's how:
- You hire a Hawaii-licensed attorney or a national mass tort firm
- Your case is filed in the MDL in Pennsylvania (or transferred there)
- All major MDL proceedings are handled by the Plaintiffs' Steering Committee
- You participate through your attorney, primarily via written correspondence and phone
- If your case goes to individual trial, it may be remanded to a federal court in Hawaii
Hawaii State Bar Resources
To find a licensed attorney in Hawaii, you can use the official state bar's attorney referral service:
Neighboring State Resources
Key Cities in Hawaii
GLP-1 drug users across Hawaii — including Honolulu, East Honolulu, Pearl City, Hilo, Kailua — are eligible to participate in MDL 3163 regardless of their city.